PMV Pharmaceuticals (PMVP) Exchange Rate Effect (2024 - 2026)
PMV Pharmaceuticals' (PMVP) quarterly Exchange Rate Effect came in at $2000.0 in Q1 2026, down 71.43% YoY from $7000.0 in Q1 2025, and up 300.0% on a QoQ basis from -$1000.0 in Q4 2025.
PMV Pharmaceuticals (PMVP) Exchange Rate Effect (2024 - 2026) Analysis & Trends
PMV Pharmaceuticals (PMVP) has 3 years of Exchange Rate Effect data on file, last reported at $2000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 71.43% year-over-year to $2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2000.0 (down 66.67% YoY) and the FY2025 annual result came in at $7000.0, up 120.0% from the prior year.
- Exchange Rate Effect climbed to $2000.0 in Q1 2026, from -$1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $7000.0 in Q1 2025 to a low of -$34000.0 in Q1 2024.
- A 3-year average of -$2888.9 and a median of $2000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 120.59% in 2025, down 116.67% in 2025.
- Tracing PMVP's Exchange Rate Effect over 3 years: stood at -$11000.0 in 2024, then jumped by 90.91% to -$1000.0 in 2025, then jumped by 300.0% to $2000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $2000.0 (Q1 2026), -$1000.0 (Q4 2025), and $2000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PMV Pharmaceuticals | 70.74 Mn | -8.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | -11,000.00 |
| Dec 31, 2024 | -11,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | -34,000.00 |
| Mar 31, 2024 | -34,000.00 |